CHINA LIFE (02628.HK) -2.520 (-9.211%) Short selling $485.93M; Ratio 25.139% charted a 44.1% surge in net profit in 2025, yet its stock price came under pressure this morning (26th), opening 0.51% lower. With expanded decline, the stock bottomed at HKD25.9, marking a more than four-month low. It last stood at HKD25.92, down 5.26%, with a turnover of 22.2669 million shares, involving HKD585 million.
Last year, China Life's revenue added by 16.5% YoY to RMB616.065 billion, and net profit grew 44.1% YoY to RMB154.078 billion, with an EPS of RMB5.45. The company proposed a final dividend of RMB6.18 per 10 shares, with a total annual dividend of RMB8.56 per 10 shares, bringing the total dividend distribution to RMB24.195 billion, up 31.7% YoY.
UBS stated that China Life's 2025 results met expectations, with robust NBV growth, and cut the target price from HKD42 to HKD40, maintaining a Buy rating. Citi commented that China Life's 2025 results were strong, with NBV growing 36% YoY, largely in line with the broker's expectations.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-03-26 12:25.)
AASTOCKS Financial News
Website: www.aastocks.com